Biopharma Cold Chain Resources

Whether you’re new to cold chain regulatory requirements or a seasoned expert in shipping validations, Modality Solutions offers expert perspectives on the biopharmaceutical cold chain industry.

Press Release

Modality Solutions Achieves ISO 9001:2015 Recertification, Expands Certification Scope to Greenwood Laboratory

Modality Solutions has successfully achieved recertification to the ISO 9001:2015 standard, reaffirming its commitment...

read Details

Press Release

Modality Solutions Achieves ISO 9001:2015 Recertification, Expands Certification Scope to Greenwood Laboratory

Modality Solutions, Suttons Creek, CLINTREX, and ToxStrategies—announce their unification under a new brand: BlueRidge Life Sciences

Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...

read Details

Biologic Cell & Gene Client Type Drug-Device Combo Products Emerging BioPharma Pharmaceutical Press Release Regulatory Filing

Modality Solutions’ New Greenwood Lab Slashes Lead Times and Expands Testing

Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...

read Details

Press Release

Modality Solutions’ New Greenwood Lab Slashes Lead Times and Expands Testing

Vertex announces UK approval for CASGEVY™

Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...

read Details

Press Release

Vertex announces UK approval for CASGEVY™

Melinta Therapeutics announces FDA approval of REZZAYO™

Congratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...

read Details

Press Release

Melinta Therapeutics announces FDA approval of REZZAYO™

Iveric Bio announces FDA approval for IZERVAY™️️

Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...

read Details

Press Release

Iveric Bio announces FDA approval for IZERVAY™️️

Incyte announces FDA approval for Zynyz™

Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...

read Details

Press Release

Incyte announces FDA approval for Zynyz™

Amicus Therapeutics announces EC approval for Pombiliti™

Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...

read Details

Press Release

Amicus Therapeutics announces EC approval for Pombiliti™

Acadia Pharmaceuticals, Inc. announces FDA Approval of Daybue

The team at Acadia Pharmaceuticals Inc. announced FDA Approval on their drug Daybue, for...

read Details

Press Release

Acadia Pharmaceuticals, Inc. announces FDA Approval of Daybue

Atara Biotherapeutics Announces EU Approval

The team at Atara Biotherapeutics announced EU Approval on their allogeneic T-cell therapy to treat adult...

read Details

Press Release